SCHEMBL22889012

SCHEMBL22889012

c1ccc(-c2nc(-c3cccc(-c4cc5ccc(-c6ccccc6-c6ccccc6)cc5c5ccccc45)c3)nc(-c3cccc4c3sc3ccccc34)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.45
PRKDC P78527 4/20 0.34
LIMK1 P53667 3/20 0.33
PARP14 Q460N5 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
F9 P00740 1/20 0.33
SLC9A1 P19634 1/20 0.32
MAPT P10636 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
ADORA2A P29274 2/20 0.31
ADORA1 P30542 2/20 0.31
S1PR5 Q9H228 2/20 0.31
CYP11B1 P15538 1/20 0.31
S1PR4 O95977 1/20 0.31
PIM3 Q86V86 1/20 0.31
ADORA3 P0DMS8 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21304339 0.98 ALOX5 (0.44) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304322 0.98 ALOX5 (0.47) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL22889249 0.97 ALOX5 (0.44) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304326 0.96 ALOX5 (0.45) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304337 0.96 ALOX5 (0.45) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304891 0.95 ALOX5 (0.43) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304319 0.94 ALOX5 (0.43) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304321 0.94 ALOX5 (0.46) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL22889413 0.93 ALOX5 (0.45) ALOX5PRKDCLIMK1PARP14TNKS
SCHEMBL21304324 0.93 ALOX5 (0.44) ALOX5PRKDCLIMK1PARP14TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885PRKDC 4797/4885LIMK1 150/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885PRKDC 4796/4885LIMK1 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.